Tag Archive for: Neogap Therapeutics AB

Swedish AI specialist Neogap Therapeutics AB will secect antigens for Cellerys AG, which wants to establish immune tolerance in a  Phase II MS trial.

Swedish Neogap Therapeutics got a new Chief Medical Officer (CMO). Dr Hanjing Xie has recently started her new position at the Stockholm-based biotech company.